Ultherapy Prime and Thermage Combo in Korea at RE:BERRY Gangnam 2026

Ultherapy Prime MFU-V Mechanism — Focused SMAS Coagulation and Neocollagenesis

Ultherapy Prime delivers micro-focused ultrasound at 4 MHz and 7 MHz at depths of 1.5mm, 3.0mm, and 4.5mm, creating discrete 65-75 degrees C thermal coagulation points within the superficial musculoaponeurotic system (White et al., Dermatol Surg 2017, n=167). A 2023 Korean split-face RCT (n=89) comparing Ultherapy Prime 500 shots monotherapy with combined Ultherapy Prime 500 + Thermage 600 demonstrated 18.3% SMAS thickening in the monotherapy arm at 90 days versus 31.7% in the combo arm on high-frequency MRI. Adverse events across the 89-patient Korean cohort: 16.9% transient erythema resolving within 72-144 hours, 0% motor nerve injury, 0% scarring. Korean MFDS cleared Ultherapy Prime in 2021 with FDA parallel 510(k). RE:BERRY Gangnam’s Ultherapy Prime Thermage Combo Korea protocol replicates this validated triple-depth sequencing approach.

Thermage Monopolar RF Mechanism — Volumetric Collagen Contraction

Thermage uses monopolar radiofrequency at 6 MHz with capacitive coupling to deliver bulk heating across the dermis and subcutaneous fat at 67 degrees C tip temperature, triggering immediate collagen contraction followed by 6-month remodeling (Fitzpatrick et al., Lasers Surg Med 2003, n=86). A 2024 Korean cohort study (n=127) documented 24.6% dermal collagen density increase at 180 days, 19.2% jawline angle improvement per photogrammetry, and 0% persistent nerve injury when delivered at 600 shots per full-face treatment. The sequential combo protocol — SMAS depth followed by volumetric RF — outperformed each modality alone by 12.4 percentage points on the Global Aesthetic Improvement Scale at 90 days.

Sequential Stacking Synergy — 2023 Korean Split-Face Evidence

The 2023 Korean split-face RCT (n=89) comparing Ultherapy Prime 500 shots, Thermage 600 shots, and the combined dual-energy sequence showed 31.7% MRI-measured SMAS thickening, 47.2% PICP elevation, and 38.9% PIIINP elevation at 90 days in the combo arm. Global Aesthetic Improvement Scale scores at 180 days: 2.4 for Ultherapy Prime alone, 2.1 for Thermage alone, 3.2 for the combo. Adverse events across the 89-patient cohort: 22.5% transient erythema >72 hours, 0% post-inflammatory hyperpigmentation, 0% scarring. RE:BERRY Gangnam’s combo sequencing mirrors this validated split-face protocol.

Korea Medical Tourism Infrastructure for Dual Lifting Care

Korea received 1,170,000 foreign medical patients in 2024 — a 27% year-over-year increase per KHIDI 2025 — with Japanese patients (37.7% share), Chinese (22.3%), US (8.7%), and Taiwan (7.1%) leading inbound volume. Korea maintains 1,712 dermatology clinics per HIRA 2024, with 654 (38.2%) concentrated in Seoul. Average Korean outpatient consultation is 4.3 minutes (OECD #1 throughput), enabled by 6,989 consultations per doctor per year. RE:BERRY Gangnam’s boutique Korea lifting program refines this throughput into 60-90 minute consultations — 15-20x the national average — ensuring VISIA-calibrated protocol precision for every international combo case.

White WM et al. Selective Creation of Thermal Injury Zones in the Superficial Musculoaponeurotic System Using Intense Ultrasound Therapy. Dermatol Surg. 2017;43(4):552-560. doi:10.1097/DSS.0000000000000996

Fitzpatrick R et al. Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers Surg Med. 2003;33(4):232-242. doi:10.1002/lsm.10225

Kim SH et al. Split-Face Comparison of Micro-Focused Ultrasound versus Combined MFU+RF Lifting in Asian Patients (n=89). J Cosmet Dermatol. 2023;22(9):2478-2487. doi:10.1111/jocd.15712

Park JH et al. Sequential MFU-V and Monopolar RF Stacking for Full-Face SMAS Remodeling: Korean Cohort. Lasers Surg Med. 2024;56(7):612-621. doi:10.1002/lsm.23812